News from Bayer
March 21, 2023
UN 2023 Water Conference:
Bayer pledges to help tackle global water crisis with new water strategy
March 20, 2023
Not intended for U.S. and UK Media
Nubeqa™ (darolutamide) approved for additional prostate cancer indication in China
March 01, 2023
Not intended for U.S. and UK Media
Nubeqa™ (darolutamide) receives EU approval for additional indication in prostate cancer